ROCK CREEK PHARMACEUTICALS INC COM STK (DE)
RCPI
RCPI was delisted on the 4th of November, 2015.
3 hedge funds and large institutions have $0 invested in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less capital invested
Capital invested by funds: $3.02K → $0 (-$3.02K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
WealthPLAN Partners
Omaha,
Nebraska
|
-$22 |
RCPI Hedge Fund Activity: Q3 2016 in Review
3 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) for Q3 2016, worth a combined $0 — down 100% from $3.02K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RCPI and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was WealthPLAN Partners, exiting entirely with an estimated $22 sold.
- 3 institutional investors held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) as of Q3 2016, down from 5 in Q2 2016.
- Funds reported $0 of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) stock for Q3 2016, down 100% quarter-over-quarter.
- 0 funds opened new ROCK CREEK PHARMACEUTICALS INC COM STK (DE) positions in Q3 2016 and 2 closed out, a net change of -2 holders.
- The largest ROCK CREEK PHARMACEUTICALS INC COM STK (DE) seller in Q3 2016 was WealthPLAN Partners, an estimated $22 sold.
Based on aggregated 13F filings for Q3 2016.